Seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the Paso del Norte region of the United States – Mexico border
<p>Abstract</p> <p>Background</p> <p>The region situated where the borders of Mexico, Texas and New Mexico meet is known as 'Paso del Norte'. The Paso del Norte Collaborative was formed to study the seroprevalence of select pathogens and associated risk behavi...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-11-01
|
Series: | Harm Reduction Journal |
Online Access: | http://www.harmreductionjournal.com/content/5/1/33 |
id |
doaj-485585a2112441b984e1335c86e4c89d |
---|---|
record_format |
Article |
spelling |
doaj-485585a2112441b984e1335c86e4c89d2020-11-24T23:58:13ZengBMCHarm Reduction Journal1477-75172008-11-01513310.1186/1477-7517-5-33Seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the Paso del Norte region of the United States – Mexico borderArbona SoniaCruz MichelleMueller MarkFoster Lily NBaumbach Joan PMelville SharonRamos RebecaStrathdee Steffanie A<p>Abstract</p> <p>Background</p> <p>The region situated where the borders of Mexico, Texas and New Mexico meet is known as 'Paso del Norte'. The Paso del Norte Collaborative was formed to study the seroprevalence of select pathogens and associated risk behaviors among injection drug users (IDUs) in the region.</p> <p>Methods</p> <p>Respondent-driven sampling (RDS) was used: 459 IDU participants included 204 from Mexico; 155 from Texas; and 100 from New Mexico. Each of the three sites used a standardized questionnaire that was verbally administered and testing was performed for select bloodborne infections.</p> <p>Results</p> <p>Participants were mostly male (87.4%) and Hispanic/Latino (84.7%) whose median age was 38. In Mexico, Texas and New Mexico, respectively: hepatitis B virus (HBV) was seen in 88.3%, 48.6% and 59.6% of participants; hepatitis C virus (HCV) in 98.7%, 76.4% and 80.0%; human immunodeficiency virus (HIV) in 2.1%, 10.0% and 1.0%; and syphilis in 4.0%, 9.9% and 3.0%. Heroin was the drug injected most often. More IDUs in New Mexico were aware of and used needle exchange programs compared with Texas and Mexico.</p> <p>Conclusion</p> <p>There was mixed success using RDS: it was more successfully applied after establishing good working relationships with IDU populations. Study findings included similarities and distinctions between the three sites that will be used to inform prevention interventions.</p> http://www.harmreductionjournal.com/content/5/1/33 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Arbona Sonia Cruz Michelle Mueller Mark Foster Lily N Baumbach Joan P Melville Sharon Ramos Rebeca Strathdee Steffanie A |
spellingShingle |
Arbona Sonia Cruz Michelle Mueller Mark Foster Lily N Baumbach Joan P Melville Sharon Ramos Rebeca Strathdee Steffanie A Seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the Paso del Norte region of the United States – Mexico border Harm Reduction Journal |
author_facet |
Arbona Sonia Cruz Michelle Mueller Mark Foster Lily N Baumbach Joan P Melville Sharon Ramos Rebeca Strathdee Steffanie A |
author_sort |
Arbona Sonia |
title |
Seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the Paso del Norte region of the United States – Mexico border |
title_short |
Seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the Paso del Norte region of the United States – Mexico border |
title_full |
Seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the Paso del Norte region of the United States – Mexico border |
title_fullStr |
Seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the Paso del Norte region of the United States – Mexico border |
title_full_unstemmed |
Seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the Paso del Norte region of the United States – Mexico border |
title_sort |
seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the paso del norte region of the united states – mexico border |
publisher |
BMC |
series |
Harm Reduction Journal |
issn |
1477-7517 |
publishDate |
2008-11-01 |
description |
<p>Abstract</p> <p>Background</p> <p>The region situated where the borders of Mexico, Texas and New Mexico meet is known as 'Paso del Norte'. The Paso del Norte Collaborative was formed to study the seroprevalence of select pathogens and associated risk behaviors among injection drug users (IDUs) in the region.</p> <p>Methods</p> <p>Respondent-driven sampling (RDS) was used: 459 IDU participants included 204 from Mexico; 155 from Texas; and 100 from New Mexico. Each of the three sites used a standardized questionnaire that was verbally administered and testing was performed for select bloodborne infections.</p> <p>Results</p> <p>Participants were mostly male (87.4%) and Hispanic/Latino (84.7%) whose median age was 38. In Mexico, Texas and New Mexico, respectively: hepatitis B virus (HBV) was seen in 88.3%, 48.6% and 59.6% of participants; hepatitis C virus (HCV) in 98.7%, 76.4% and 80.0%; human immunodeficiency virus (HIV) in 2.1%, 10.0% and 1.0%; and syphilis in 4.0%, 9.9% and 3.0%. Heroin was the drug injected most often. More IDUs in New Mexico were aware of and used needle exchange programs compared with Texas and Mexico.</p> <p>Conclusion</p> <p>There was mixed success using RDS: it was more successfully applied after establishing good working relationships with IDU populations. Study findings included similarities and distinctions between the three sites that will be used to inform prevention interventions.</p> |
url |
http://www.harmreductionjournal.com/content/5/1/33 |
work_keys_str_mv |
AT arbonasonia seroprevalenceofselectbloodbornepathogensandassociatedriskbehaviorsamonginjectiondrugusersinthepasodelnorteregionoftheunitedstatesmexicoborder AT cruzmichelle seroprevalenceofselectbloodbornepathogensandassociatedriskbehaviorsamonginjectiondrugusersinthepasodelnorteregionoftheunitedstatesmexicoborder AT muellermark seroprevalenceofselectbloodbornepathogensandassociatedriskbehaviorsamonginjectiondrugusersinthepasodelnorteregionoftheunitedstatesmexicoborder AT fosterlilyn seroprevalenceofselectbloodbornepathogensandassociatedriskbehaviorsamonginjectiondrugusersinthepasodelnorteregionoftheunitedstatesmexicoborder AT baumbachjoanp seroprevalenceofselectbloodbornepathogensandassociatedriskbehaviorsamonginjectiondrugusersinthepasodelnorteregionoftheunitedstatesmexicoborder AT melvillesharon seroprevalenceofselectbloodbornepathogensandassociatedriskbehaviorsamonginjectiondrugusersinthepasodelnorteregionoftheunitedstatesmexicoborder AT ramosrebeca seroprevalenceofselectbloodbornepathogensandassociatedriskbehaviorsamonginjectiondrugusersinthepasodelnorteregionoftheunitedstatesmexicoborder AT strathdeesteffaniea seroprevalenceofselectbloodbornepathogensandassociatedriskbehaviorsamonginjectiondrugusersinthepasodelnorteregionoftheunitedstatesmexicoborder |
_version_ |
1725451133480075264 |